A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context
Background Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%–69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements. Objective To...
Gespeichert in:
| Veröffentlicht in: | Global advances in health and medicine 2024-01, Vol.13, p.27536130241268240 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 27536130241268240 |
| container_title | Global advances in health and medicine |
| container_volume | 13 |
| creator | Brodsky, Marc Hartnett, Josette Houston, Kaly Rose, Suzanne J. |
| description | Background
Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%–69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.
Objective
To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.
Methods
This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.
Results
Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.
Conclusion
Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations. |
| doi_str_mv | 10.1177/27536130241268240 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3085686506</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_27536130241268240</sage_id><sourcerecordid>3149771092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-e47f12912e1390f427d71c3c3b53e1685b6149585d1e204d795fd23d353bceee3</originalsourceid><addsrcrecordid>eNp1kclOwzAQhi0EohX0AbggS1y4BLzEsXMsZSkSEkiFc-TEkzZVlmI7iL49rloWgTjN6Nc3_2wInVByQamUl0wKnlBOWExZolhM9tBwo0Ubcf9HPkAj55aEEJYyppQ6RAOeEkmYokNkxvhpoW2ji3V0pR0Y_Jg7sG_aV12razzzvVnjrsTX1Rycj1RIwGu7xrN-taqhgdbjqsUaT7rW9Q1YPAVd-0WhLWw0D-_-GB2UunYw2sUj9HJ78zyZRg-Pd_eT8UNUsJT7CGJZUpZSBjQMWMZMGkkLXvBccKCJEnlC41QoYSgwEhuZitIwbrjgeQEA_Aidb31Xtnvtw7hZU7kC6lq30PUu40SJRCWCJAE9-4Uuu96GjQMVmkhJScoCRbdUYTvnLJTZylZN2D6jJNt8IfvzhVBzunPu8wbMV8XnzQNwsQWcnsN32_8dPwDlw4y5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149771092</pqid></control><display><type>article</type><title>A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context</title><source>Sage Journals GOLD Open Access 2024</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Brodsky, Marc ; Hartnett, Josette ; Houston, Kaly ; Rose, Suzanne J.</creator><creatorcontrib>Brodsky, Marc ; Hartnett, Josette ; Houston, Kaly ; Rose, Suzanne J.</creatorcontrib><description>Background
Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%–69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.
Objective
To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.
Methods
This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.
Results
Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.
Conclusion
Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations.</description><identifier>ISSN: 2753-6130</identifier><identifier>ISSN: 2164-957X</identifier><identifier>EISSN: 2753-6130</identifier><identifier>EISSN: 2164-9561</identifier><identifier>DOI: 10.1177/27536130241268240</identifier><identifier>PMID: 39070281</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Observational studies</subject><ispartof>Global advances in health and medicine, 2024-01, Vol.13, p.27536130241268240</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024.</rights><rights>The Author(s) 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c293t-e47f12912e1390f427d71c3c3b53e1685b6149585d1e204d795fd23d353bceee3</cites><orcidid>0000-0002-9365-7241 ; 0000-0002-7475-4265 ; 0000-0001-5770-826X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/27536130241268240$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/27536130241268240$$EHTML$$P50$$Gsage$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,21945,27830,27901,27902,44921,45309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39070281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brodsky, Marc</creatorcontrib><creatorcontrib>Hartnett, Josette</creatorcontrib><creatorcontrib>Houston, Kaly</creatorcontrib><creatorcontrib>Rose, Suzanne J.</creatorcontrib><title>A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context</title><title>Global advances in health and medicine</title><addtitle>Glob Adv Integr Med Health</addtitle><description>Background
Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%–69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.
Objective
To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.
Methods
This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.
Results
Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.
Conclusion
Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations.</description><subject>Observational studies</subject><issn>2753-6130</issn><issn>2164-957X</issn><issn>2753-6130</issn><issn>2164-9561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kclOwzAQhi0EohX0AbggS1y4BLzEsXMsZSkSEkiFc-TEkzZVlmI7iL49rloWgTjN6Nc3_2wInVByQamUl0wKnlBOWExZolhM9tBwo0Ubcf9HPkAj55aEEJYyppQ6RAOeEkmYokNkxvhpoW2ji3V0pR0Y_Jg7sG_aV12razzzvVnjrsTX1Rycj1RIwGu7xrN-taqhgdbjqsUaT7rW9Q1YPAVd-0WhLWw0D-_-GB2UunYw2sUj9HJ78zyZRg-Pd_eT8UNUsJT7CGJZUpZSBjQMWMZMGkkLXvBccKCJEnlC41QoYSgwEhuZitIwbrjgeQEA_Aidb31Xtnvtw7hZU7kC6lq30PUu40SJRCWCJAE9-4Uuu96GjQMVmkhJScoCRbdUYTvnLJTZylZN2D6jJNt8IfvzhVBzunPu8wbMV8XnzQNwsQWcnsN32_8dPwDlw4y5</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Brodsky, Marc</creator><creator>Hartnett, Josette</creator><creator>Houston, Kaly</creator><creator>Rose, Suzanne J.</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9365-7241</orcidid><orcidid>https://orcid.org/0000-0002-7475-4265</orcidid><orcidid>https://orcid.org/0000-0001-5770-826X</orcidid></search><sort><creationdate>202401</creationdate><title>A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context</title><author>Brodsky, Marc ; Hartnett, Josette ; Houston, Kaly ; Rose, Suzanne J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-e47f12912e1390f427d71c3c3b53e1685b6149585d1e204d795fd23d353bceee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Observational studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brodsky, Marc</creatorcontrib><creatorcontrib>Hartnett, Josette</creatorcontrib><creatorcontrib>Houston, Kaly</creatorcontrib><creatorcontrib>Rose, Suzanne J.</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Global advances in health and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brodsky, Marc</au><au>Hartnett, Josette</au><au>Houston, Kaly</au><au>Rose, Suzanne J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context</atitle><jtitle>Global advances in health and medicine</jtitle><addtitle>Glob Adv Integr Med Health</addtitle><date>2024-01</date><risdate>2024</risdate><volume>13</volume><spage>27536130241268240</spage><pages>27536130241268240-</pages><issn>2753-6130</issn><issn>2164-957X</issn><eissn>2753-6130</eissn><eissn>2164-9561</eissn><abstract>Background
Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%–69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.
Objective
To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.
Methods
This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.
Results
Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.
Conclusion
Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39070281</pmid><doi>10.1177/27536130241268240</doi><orcidid>https://orcid.org/0000-0002-9365-7241</orcidid><orcidid>https://orcid.org/0000-0002-7475-4265</orcidid><orcidid>https://orcid.org/0000-0001-5770-826X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2753-6130 |
| ispartof | Global advances in health and medicine, 2024-01, Vol.13, p.27536130241268240 |
| issn | 2753-6130 2164-957X 2753-6130 2164-9561 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3085686506 |
| source | Sage Journals GOLD Open Access 2024; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Observational studies |
| title | A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T07%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Pharmacy-Based%20Observational%20Study%20of%20Digest-8%20Dietary%20Supplement%20in%20a%20Consumer%20Healthcare%20Context&rft.jtitle=Global%20advances%20in%20health%20and%20medicine&rft.au=Brodsky,%20Marc&rft.date=2024-01&rft.volume=13&rft.spage=27536130241268240&rft.pages=27536130241268240-&rft.issn=2753-6130&rft.eissn=2753-6130&rft_id=info:doi/10.1177/27536130241268240&rft_dat=%3Cproquest_cross%3E3149771092%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3149771092&rft_id=info:pmid/39070281&rft_sage_id=10.1177_27536130241268240&rfr_iscdi=true |